|
End-of-day quote
Taipei Exchange
08/10/2026
|
5-day change | 1st Jan Change | ||
| 22.80 TWD | -0.87% |
|
+2.01% | -11.46% |
| 08-13 | GlycoNex Incorporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 08-03 | GlycoNex Inc Doses First Patient In Phase I Trial Of GNX1021 | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.87% | +2.01% | +2.93% | -11.63% | -11.46% | -6.94% | -19.86% | -9.34% | -39.36% | 81.21M | ||
| -3.19% | -3.19% | +5.71% | +36.94% | +78.73% | +44.60% | +87.98% | +6.02% | - | 74.68B | ||
| -15.86% | -16.16% | -18.50% | -11.78% | -1.56% | +2.68% | +51.09% | +176.38% | +4,700.00% | 58.7B | ||
| -2.39% | +0.50% | +1.33% | -1.68% | +4.76% | +3.41% | +31.33% | -18.54% | +202.09% | 48.36B | ||
| -7.98% | -10.68% | -11.29% | -3.09% | +130.89% | +284.58% | +622.05% | +562.01% | - | 43.05B | ||
| -1.04% | -2.92% | -2.36% | +24.20% | +12.29% | +26.17% | +26.84% | +4.49% | +217.13% | 42.48B | ||
| -5.18% | -4.33% | -2.34% | +13.70% | +12.98% | -2.23% | +98.65% | -5.50% | +968.98% | 41.39B | ||
| -2.13% | +1.07% | -3.60% | +0.79% | +4.19% | +7.51% | +50.31% | +2.56% | +139.76% | 31.29B | ||
| -2.86% | -4.57% | -6.32% | -1.19% | -2.92% | -13.04% | -15.45% | -62.42% | - | 23.93B | ||
| -3.30% | -9.95% | -21.70% | -16.09% | -43.81% | -39.57% | +298.96% | +243.59% | +550.60% | 22.22B | ||
| -5.27% | +1.86% | +8.82% | +24.52% | +16.23% | +12.19% | -3.32% | -15.04% | +105.41% | 22.24B | ||
| -1.88% | -1.07% | +0.14% | +11.22% | +5.35% | +11.43% | +138.64% | +213.40% | +1,856.03% | 16.87B | ||
| -0.83% | -1.65% | -9.81% | -11.33% | +182.04% | +139.28% | +356.14% | +1,992.52% | +684.56% | 15.67B | ||
| -1.07% | +1.56% | +6.32% | +12.88% | +21.31% | +21.51% | +45.47% | -28.45% | +83.09% | 14.87B | ||
| -2.79% | -2.75% | -18.16% | -20.25% | - | - | - | - | - | 15B | ||
| -3.23% | +0.73% | +2.91% | +29.01% | +44.84% | +66.56% | +49.65% | -29.38% | +246.11% | 14.34B | ||
| +1.69% | +1.73% | +2.21% | +5.05% | +34.49% | +52.55% | +174.29% | +172.64% | +367.45% | 14.48B | ||
| -5.18% | +1.35% | -2.11% | +7.81% | -3.29% | -27.53% | +912.87% | +239.66% | +42.38% | 14.36B | ||
| -3.94% | -11.41% | +5.42% | +18.34% | +14.77% | -34.36% | - | - | - | 12.69B | ||
| -1.54% | -0.08% | +2.13% | -2.27% | -11.25% | -13.28% | -32.21% | -39.03% | +104.66% | 12.66B | ||
| Average | -3.47% | -1.18% | -2.91% | +5.26% | +25.71% | +28.19% | +159.63% | +189.20% | +681.93% | 26.97B | |
| Weighted average by Cap. | -4.63% | -1.25% | -3.74% | +8.04% | +31.58% | +37.48% | +147.34% | +150.79% | +1,102.62% |
- Stock Market
- Stocks
- 4168 Stock
- Sector GlycoNex Incorporation
Select your edition
All financial news and data tailored to specific country editions
















